MassMutual Private Wealth & Trust’s Ocular Therapeutix OCUL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.46K	Buy	760 +265	+54%	+$2.4K	﹤0.01%	1524
2026 Q1	$4.19K	Sell	495 -25	-5%	-$238	﹤0.01%	1750
2025 Q4	$6.31K	Sell	520 -20	-4%	-$243	﹤0.01%	1581
2025 Q3	$6.31K	Buy	540 +4	+0.7%	+$48	﹤0.01%	1588
2025 Q2	$4.97K	Buy	536 +216	+68%	+$1.69K	﹤0.01%	1637
2025 Q1	$2.35K	Buy	+320	New	+$2.46K	﹤0.01%	1871
2023 Q4	–	Sell	-107	Closed	-$336	–	2046
2023 Q3	$336	Hold	107	–	–	﹤0.01%	1878
2023 Q2	$552	Hold	107	–	–	﹤0.01%	1760
2023 Q1	$564	Hold	107	–	–	﹤0.01%	1659
2022 Q4	$0	Buy	107 +46	+75%	+$152	﹤0.01%	1784
2022 Q3	$0	Buy	+61	New	+$307	﹤0.01%	1748

Other funds holding OCUL

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

RZH

Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

MassMutual Private Wealth & Trust's OCUL Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Ocular Therapeutix (OCUL) stake by 54% in Q2 2026, buying an estimated $2.4K and bringing the position to 760 shares worth $7.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

MassMutual Private Wealth & Trust first reported a position in OCUL in Q3 2022 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

MassMutual Private Wealth & Trust held 760 shares of Ocular Therapeutix worth $7.46K as of Q2 2026.
MassMutual Private Wealth & Trust bought 265 Ocular Therapeutix shares in Q2 2026, an estimated $2.4K.
Ocular Therapeutix made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1524 holding.
MassMutual Private Wealth & Trust first reported a position in Ocular Therapeutix in Q3 2022 and has held it in 11 quarters since.
22 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.